Delivery Order SPE2DB20D2014-SPE2DB25FC29B
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 29, 2025, for the supply of Nitrofurantoin 25 mg/5 ml suspension in a 230 ml quantity, with a ceiling value of $6,907.65. This contract represents a firm fixed price delivery order with an ultimate completion date of July 30, 2025, and carries no set-aside designation, indicating it was competitively awarded. The pharmaceutical product will be delivered to the place of performance in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 20, 2025, for the supply of Nitrofurantoin 25 mg/5 ml suspension in a 230 ml quantity, valued at $3,014.36. This competitively awarded, firm fixed-price delivery order is scheduled for completion by August 21, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The contract carries no set-aside designation, indicating it was competed among qualified vendors in the...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 27, 2025, for the supply of Nitrofurantoin 25 mg/5 ml suspension in a 230 ml quantity, valued at $9,138.12 under firm fixed price terms. This non-set-aside, competitively awarded contract is classified as a delivery order with an ultimate completion date of August 28, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award represents a single transaction...
- The Defense Logistics Agency awarded a delivery order valued at $2,533.84 to AmerisourceBergen Drug Corp for Nitrofurantoin 25 mg/5 ml suspension (230 ml) on August 28, 2025, with an ultimate completion date of August 29, 2025. This competitively awarded, firm fixed-price delivery order is non-set-aside and will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $8,128.21 to AmerisourceBergen Drug Corp for Nitrofurantoin 25 mg/5 mL Suspension (230 mL) on August 19, 2025, with an ultimate completion date of August 20, 2025. This contract was awarded competitively with no set-aside designation under firm fixed price terms. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen Drug Corp maintains its corporate headquarters. Nitrofurantoin is a...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 18, 2025, for the supply of Nitrofurantoin Mono-MCR 100 mg tablets (100 count) with a ceiling value of $1,997.80. This firm fixed-price delivery order, with an ultimate completion date of August 19, 2025, represents a non-competitive set-aside award for pharmaceutical supplies to support federal medical procurement needs. The place of performance is listed as AmerisourceBergen's corporate office in...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $7,649.72 to AmerisourceBergen Drug Corp for the supply of Nitrofurantoin 25 mg/5 mL suspension in a 230 mL quantity. This contract was competitively awarded without a set-aside designation and operates under firm fixed price terms, with an ultimate completion date of August 21, 2025. The product will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to supply 230 ml bottles of 25 mg/5 ml Nitrofurantoin suspension. This $2,449.20 order is part of a larger indefinite delivery contract (IDC) between DLA and Amerisourcebergen Drug Corp valued at up to $999,999,999.00, which serves as the primary vehicle for the company to deliver pharmaceutical products and medical supplies...
- This delivery order, valued at $6,938.00, awards AmerisourceBergen Drug Corp the supply of Nitrofurantoin 25 mg/5 ml suspension in 230 ml quantities under a firm fixed price arrangement. The contract was competitively awarded without set-aside restrictions and is scheduled for completion by July 21, 2025. Performance will be executed from the contractor's Corporate Office location in Conshohocken, Pennsylvania. This award represents a child delivery order under AmerisourceBergen's broader...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Nitrofurantoin 25 mg/5 ml suspension, a pharmaceutical product used for the treatment of certain bacterial infections. The contract has a ceiling value of $2,666.00 and a period of performance through April 2, 2025. This award is associated with a larger Indefinite Delivery...
- SPE2DB20D2014Indefinite Delivery Contract
- SPE2DB20D2014-SPE2DB25FC29BDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on June 23, 2025, for the supply of Nitrofurantoin 25 mg/5 mL suspension (230 mL quantity) with a ceiling value of $5,067.68. This is a firm fixed-price delivery order with an ultimate completion date of June 24, 2025, and no set-aside designation was utilized. The award was competitively awarded to AmerisourceBergen's Corporate Office, with performance to be conducted at the company's location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (contract number SPE2DX), valued at $999,999,999.00 and extending through December 2026. The parent IDC serves as a comprehensive global pharmaceutical support vehicle enabling AmerisourceBergen to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs. The nitrofurantoin order represents a routine pharmaceutical procurement under this strategic vehicle, supporting the Defense Health Agency and other federal healthcare systems' medical supply needs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $5.1k | 6/23/25 |